基本信息
views: 3
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Jabs is an experienced clinician scientist and uveitis expert, with a long track record in clinical trials, cohort studies, and translational research. Dr. Jabs’ work focuses on performing clinical trials in the field of uveitis and developing ‘best practice’ guidelines for the management of the uveitides, particularly with regard to long-term outcomes of these chronic diseases. Dr. Jabs has served as the chair of numerous NIH-funded multicenter, national and international, randomized, comparative effective trials, and of long-term prospective cohort studies. He has authored over 320 peer-reviewed journal articles and over 45 book chapters.
Research Interests
Papers共 172 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Sapna Gangaputra, Craig Newcomb, Gui-Shuang Ying, Sylvia Groth, Tonetta D. Fitzgerald, Pichaporn Artornsombudh, Srishti Kothari, Siddharth S. Pujari,Douglas A. Jabs,Grace A. Levy-Clarke,Robert B. Nussenblatt, James T. Rosenbaum,
American Journal of Ophthalmology (2024)
John H Kempen,Craig W Newcomb, Terri L Washington,C Stephen Foster,Lucia Sobrin,Jennifer E Thorne,Douglas A Jabs,Eric B Suhler, James T Rosenbaum,H Nida Sen,Grace A Levy-Clarke,Robert B Nussenblatt,
Ophthalmologyno. 9 (2023): 914-923
Douglas A. Jabs,Peter McCluskey,Alan G. Palestine,Jennifer E. Thorne, The Standardization of Uveitis Nomenclature (SUN) Working Gr,Massimo Accorinti,Nisha Acharya,Radgonde Amer, Leyla S. Atmaca,Asaf Bar,Talin Barisani‐Asenbauer,Matthias D. Becker,
Clinical & Experimental Ophthalmologyno. 9 (2022): 991-1000
Ophthalmology Retina (2022)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn